Racial differences in attitudes toward personalized medicine.
V A Diaz1, A G Mainous, J K Gavin
1Department of Family Medicine, Medical University of South Carolina, Charleston, S.C., USA.
Public Health Genomics
|October 2, 2013
Summary
Racial disparities exist in personalized medicine acceptance. Non-Hispanic Black individuals reported more concerns, potentially linked to experiences of discrimination, impacting personalized medicine adoption.
Area of Science:
- Genomics and Precision Medicine
- Health Disparities Research
- Patient Attitudes and Beliefs
Background:
- Patient concerns about personalized medicine may impede its widespread adoption.
- Understanding racial differences in attitudes is crucial for equitable implementation.
- Key variables influencing these attitudes require thorough investigation.
Purpose of the Study:
- To assess racial disparities in attitudes toward personalized medicine.
- To identify factors influencing patient acceptance and concerns.
- To evaluate the impact of self-reported discrimination on these attitudes.
Main Methods:
- Survey of 190 adults in an academic primary care setting.
- Assessed awareness, acceptance, concerns, and benefits of personalized medicine.
- Logistic regression analyses controlled for demographic and experiential variables.
Main Results:
- Non-Hispanic White participants showed higher acceptance of personalized medicine compared to Non-Hispanic Black participants (94.4% vs. 81.9%).
- Non-Hispanic Black participants expressed greater concerns regarding genetic information use, consent, discrimination, and cost.
- Logistic regression indicated Non-Hispanic Black individuals and those reporting discrimination had significantly more concerns (OR=7.46 and OR=2.87, respectively).
Conclusions:
- Significant racial differences in attitudes toward personalized medicine were observed.
- Self-reported discrimination appears to be a key factor influencing concerns.
- Further research is needed to address these disparities and promote equitable personalized medicine use.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...